PolyPid (PYPD) Competitors $3.25 -0.05 (-1.52%) As of 03:56 PM Eastern Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrends PYPD vs. APYX, DHAI, TMDIF, ICAD, INO, LUCD, NTRB, BLAC, CLGN, and MODDShould you be buying PolyPid stock or one of its competitors? The main competitors of PolyPid include Apyx Medical (APYX), DIH Holding US (DHAI), Titan Medical (TMDIF), iCAD (ICAD), Inovio Pharmaceuticals (INO), Lucid Diagnostics (LUCD), Nutriband (NTRB), Bellevue Life Sciences Acquisition (BLAC), CollPlant Biotechnologies (CLGN), and Modular Medical (MODD). These companies are all part of the "medical equipment" industry. PolyPid vs. Apyx Medical DIH Holding US Titan Medical iCAD Inovio Pharmaceuticals Lucid Diagnostics Nutriband Bellevue Life Sciences Acquisition CollPlant Biotechnologies Modular Medical PolyPid (NASDAQ:PYPD) and Apyx Medical (NASDAQ:APYX) are both small-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their dividends, risk, earnings, valuation, media sentiment, analyst recommendations, community ranking, institutional ownership and profitability. Do institutionals & insiders have more ownership in PYPD or APYX? 26.5% of PolyPid shares are owned by institutional investors. Comparatively, 55.3% of Apyx Medical shares are owned by institutional investors. 24.7% of PolyPid shares are owned by insiders. Comparatively, 16.8% of Apyx Medical shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth. Which has preferable valuation and earnings, PYPD or APYX? Apyx Medical has higher revenue and earnings than PolyPid. Apyx Medical is trading at a lower price-to-earnings ratio than PolyPid, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioPolyPidN/AN/A-$23.86M-$7.81-0.41Apyx Medical$52.35M1.07-$18.71M-$0.83-1.79 Does the media favor PYPD or APYX? In the previous week, PolyPid had 1 more articles in the media than Apyx Medical. MarketBeat recorded 1 mentions for PolyPid and 0 mentions for Apyx Medical. Apyx Medical's average media sentiment score of 0.00 beat PolyPid's score of -0.50 indicating that Apyx Medical is being referred to more favorably in the news media. Company Overall Sentiment PolyPid Negative Apyx Medical Neutral Does the MarketBeat Community favor PYPD or APYX? Apyx Medical received 49 more outperform votes than PolyPid when rated by MarketBeat users. However, 78.38% of users gave PolyPid an outperform vote while only 60.94% of users gave Apyx Medical an outperform vote. CompanyUnderperformOutperformPolyPidOutperform Votes2978.38% Underperform Votes821.62% Apyx MedicalOutperform Votes7860.94% Underperform Votes5039.06% Which has more volatility and risk, PYPD or APYX? PolyPid has a beta of 1.32, meaning that its stock price is 32% more volatile than the S&P 500. Comparatively, Apyx Medical has a beta of 1.26, meaning that its stock price is 26% more volatile than the S&P 500. Do analysts recommend PYPD or APYX? PolyPid presently has a consensus target price of $10.50, suggesting a potential upside of 226.59%. Given PolyPid's stronger consensus rating and higher possible upside, research analysts plainly believe PolyPid is more favorable than Apyx Medical.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score PolyPid 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 3.00Apyx Medical 0 Sell rating(s) 2 Hold rating(s) 0 Buy rating(s) 1 Strong Buy rating(s) 2.67 Is PYPD or APYX more profitable? PolyPid has a net margin of 0.00% compared to Apyx Medical's net margin of -58.59%. Apyx Medical's return on equity of -137.98% beat PolyPid's return on equity.Company Net Margins Return on Equity Return on Assets PolyPidN/A -1,219.71% -134.48% Apyx Medical -58.59%-137.98%-36.74% SummaryPolyPid and Apyx Medical tied by winning 9 of the 18 factors compared between the two stocks. Get PolyPid News Delivered to You Automatically Sign up to receive the latest news and ratings for PYPD and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart PYPD vs. The Competition Export to ExcelMetricPolyPidSurgical & medical instruments IndustryMedical SectorNASDAQ ExchangeMarket Cap$15.43M$4.82B$5.38B$9.11BDividend YieldN/A52.58%5.37%4.00%P/E Ratio-0.4126.0587.8117.51Price / SalesN/A61.081,285.9980.25Price / CashN/A50.8936.6032.90Price / Book-2.537.864.944.66Net Income-$23.86M$13.87M$117.96M$224.69M7 Day Performance4.05%3.68%2.29%3.11%1 Month Performance-0.16%10.75%3.26%5.17%1 Year Performance-52.09%32.76%27.03%22.24% PolyPid Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)PYPDPolyPid2.5512 of 5 stars$3.25-1.5%$10.50+223.1%-50.8%$15.60MN/A-0.4280APYXApyx Medical1.121 of 5 stars$1.49-6.3%N/A-30.2%$56.09M$48.54M-1.80270Gap UpDHAIDIH Holding USN/A$1.37-5.5%N/AN/A$55.55M$64.47M0.00N/ATMDIFTitan MedicalN/A$0.47-5.3%N/A+639.8%$53.98M$17.63M-0.3850Gap DownICADiCAD1.1986 of 5 stars$1.91+0.5%N/A+27.6%$50.69M$18.94M-14.69140News CoverageGap DownINOInovio Pharmaceuticals4.2207 of 5 stars$1.90-4.0%$12.40+552.6%-97.9%$49.59M$203,413.00-0.91320LUCDLucid Diagnostics2.3845 of 5 stars$0.82-2.5%$3.63+343.7%-41.9%$48.48M$4.19M-0.7270News CoverageNTRBNutriband0.2561 of 5 stars$4.23+2.4%N/A+55.4%$46.98M$2.02M-5.9610Gap DownBLACBellevue Life Sciences AcquisitionN/A$11.35flatN/AN/A$45.87MN/A0.00N/ACLGNCollPlant Biotechnologies2.1003 of 5 stars$3.93-6.4%$12.50+218.1%-24.0%$45.02M$650,000.00-2.5570Positive NewsMODDModular Medical2.4122 of 5 stars$1.26-4.5%$5.00+296.8%-32.4%$43.71MN/A-2.0020Positive News Related Companies and Tools Related Companies Apyx Medical Alternatives DIH Holding US Alternatives Titan Medical Alternatives iCAD Alternatives Inovio Pharmaceuticals Alternatives Lucid Diagnostics Alternatives Nutriband Alternatives Bellevue Life Sciences Acquisition Alternatives CollPlant Biotechnologies Alternatives Modular Medical Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:PYPD) was last updated on 1/21/2025 by MarketBeat.com Staff From Our PartnersCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode in 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | SponsoredMost People Are Dead Wrong.Turn on any financial news outlet at any given moment and within minutes you're guaranteed to see headlines ab...Brownstone Research | SponsoredThis coin could surge during Trump’s first week in office.Juan has never had a losing trade on Bitcoin. And he booked gains of 312% on Chainlink … Now, he says one v...Weiss Ratings | SponsoredElon’s New AI Firm REVEALEDNvidia’s AI chip … the H100 … has been the holy grail of artificial intelligence… Until now. Because Elo...Paradigm Press | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | SponsoredMust-See: 5-Second Trump PredictionPresident Trump's prediction is about to become a reality... Opening a rare window of opportunity for you t...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding PolyPid Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share PolyPid With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free PYPD Stock Alerts